SCHEMBL25812122

SCHEMBL25812122

CSc1ccc(NC(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 10/20 0.76
NPC1 O15118 9/20 0.76
SMN1; SMN2 Q16637 3/20 0.64
MAPT P10636 2/20 0.64
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
USP2 O75604 1/20 0.59
POLB P06746 1/20 0.59
PLK1 P53350 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.57
NFKB1 P19838 1/20 0.57
NFKB2 Q00653 1/20 0.57
RELA Q04206 1/20 0.57
TNF P01375 1/20 0.57
NAMPT P43490 1/20 0.55
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
MCL1 Q07820 1/20 0.55
MMP2 P08253 1/20 0.53
MMP9 P14780 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12310125 0.87 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL14580374 0.87 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL15214321 0.87 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL27181403 0.87 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL822378 0.87 RAB9A (1.00) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL23977686 0.86 POLB (0.59) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL2244112 0.85 NPC1 (0.64) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL95932 0.85 PLK1 (0.56) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL2563371 0.84 NPC1 (0.66) RAB9ANPC1SMN1; SMN2MAPTMEN1
SCHEMBL7292377 0.83 TRPV1 (0.71) RAB9ANPC1SMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease US GOV VETERANS AFFAIRS (US) 2023-07-13 US disclosed
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2023-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643394-B2 Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease KIF15, KLF5, KLF10 RAB9A 1697/4885NPC1 834/4885SMN1; SMN2 45/4885
US-20230219893-A1 Krüppel-Like Factor 15 (KLF15) Small Molecule Agonists in Kidney Disease KIF15, KLF5, KLF10 RAB9A 1697/4885NPC1 834/4885SMN1; SMN2 45/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.